The founders of the Strategic Access Fund (the “Fund”) believe that the Cannabis industry offers investors exceptional opportunities to generate above-market and outsized returns on investment.State-legalized Cannabis is a $3.5 billion market that is growing at a 53% compound annual rate – one of th…
The founders of the Strategic Access Fund (the “Fund”) believe that the Cannabis industry offers investors exceptional opportunities to generate above-market and outsized returns on investment.
State-legalized Cannabis is a $3.5 billion market that is growing at a 53% compound annual rate – one of the fastest-growing sectors of the healthcare industry and the U.S. economy.
Currently in 23 states and the District of Columbia, the industry anticipates sustained growth as other states legalize Cannabis and as existing state markets mature.
Medical Cannabis is used to treat debilitating symptoms of conditions such as cancer, epilepsy, multiple sclerosis and chronic pain that affect over 20% of the U.S. population – or 65 million Americans.
We see medical Cannabis investments as a rare opportunity to do well by doing good.
Federal prohibition of Cannabis has created a window of opportunity to invest in the industry at a time when major corporate and financial institutions are unable to participate.
We believe that the federal government will ultimately legalize Cannabis for medical use.
Our experience and belief is that owners and operators who comply strictly with state law and Justice Department guidelines will not be subjected to federal enforcement actions.
The Strategic Access Fund offers accredited investors access to the rapidly-emerging Cannabis industry and the opportunity to invest alongside financial professionals with a record of success in the sector.
The Fund is offering subscriptions to a $40-60 million fund of investment capital to be deployed into high-value Cannabis operating companies and ancillary businesses that serve the industry.
The Fund will capitalize on the General Partner’s investment management, operating models, strategies, sector experience, access to proven portfolio companies and new investment opportunities.
We will prioritize investments into companies that hold state operating licenses or operate state- licensed entities, which offer attractive financial dynamics and high return on investment.
The portfolio will be managed to focus on accumulating medical Cannabis assets and building a regional platform in New England as a precursor to a national platform; management will also seek to build portfolio value by:
Applying proven operating models to create efficiencies and lower costs Focusing production on high value-added products Building regional and national brands
The Strategic Access Fund seeks to deliver total investment returns comparable to those of private equity and venture capital funds as well as the prospect for outsized returns in best-case industry scenarios.
We are targeting annual IRR of 36% over 10 years on a $40 million investment.
Home About Contact Cannabiz "More Than Just Medicine"
STRATEGIC ACCESS FUND
Vision
The Strategic Access Fund, L.P. (“the Fund”) was created to provide accredited investors with access to the rapidly-emerging Cannabis industry alongside experienced financial professionals with a record of success in the sector.
The Fund was established by Cannabiz Capital Management, LLC (“Cannabiz”), whose founders include early Cannabis industry investors who were inspired to launch the Strategic Access Fund by the success of their investment portfolio and experience in the sector.
The objective of the Strategic Access partnership is to build and manage a diversified portfolio of private Cannabis and Cannabis-related companies with significant income and growth potential.
General Partner and Manager
Cannabiz will serve as General Partner of the Strategic Access Fund and will be responsible for overseeing management of the duties and operations of the Fund. In the role of General Partner, Cannabiz will administer the Fund, allocate capital and manage the investment portfolio.
Cannabiz, its members and affiliates will make an aggregate capital commitment of 1% of the total amount subscribed by the Fund. The company intends to meet this obligation by contributing equity in Cannabis companies that will advance the Fund’s investment strategy and generate immediate dividend income to the limited partners of the Strategic Access Fund.
As General Partner of the Fund, Cannabiz will contribute the investment management and sector experience, access to proven portfolio companies and new investment opportunities that Cannabiz will contribute as General Partner of the Fund. Cannabiz founders and executives have over 100 years of experience in investment analysis as well as management, business, finance and law. The team’s Cannabis investing, operations and business development experience includes:
Expertise in evaluating the performance and value of industry assets Financial, operating and investment management experience based on 2 cultivation centers, five dispensaries and a Cannabis-infused product manufacturing operation Ability to invest immediately in proven assets and participate in growing an existing platform Network of investment leads and sources within the U.S. Cannabis industry
The investment program of the Strategic Access Fund will be vetted by an Investment Committee of at least three members who will review capital allocation proposals and provide independent perspectives on funding decisions.
Members of the Investment Committee are selected for their experience, judgement as well as business and investment acumen.
Members of an Advisory Board will contribute counsel to Fund management on an as-needed basis. Advisory Board members are chosen to provide industry and professional expertise.
Copyright @ Cannabiz. All rights reserved.
Team (1)
Sectors Cannabiz serves:
Financial Services
Consumer Goods
Join Axial's Private M&A Platform
Cannabiz connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
